Dr. Leitao on the Role of Surgery in Ovarian Cancer

Mario M. Leitao, Jr, MD, FACOG, FACS
Published: Tuesday, Nov 07, 2017



Mario M. Leitao Jr, MD, FACOG, FACS, fellowship director, gynecology service, director, Minimal Access and Robotic Surgery Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, discusses the role of surgery for patients with ovarian cancer.

Surgery continues to have a role in the treatment of patients with ovarian cancer, says Leitao. Now that surgeons can perform smaller incisions with less complications, more women are willing to consider surgery as an option.

Surgery also plays a role in fertility preservation, explains Leitao. Select patients with early-stage ovarian cancer can receive surgery, chemotherapy, and potentially still give birth.



Mario M. Leitao Jr, MD, FACOG, FACS, fellowship director, gynecology service, director, Minimal Access and Robotic Surgery Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, discusses the role of surgery for patients with ovarian cancer.

Surgery continues to have a role in the treatment of patients with ovarian cancer, says Leitao. Now that surgeons can perform smaller incisions with less complications, more women are willing to consider surgery as an option.

Surgery also plays a role in fertility preservation, explains Leitao. Select patients with early-stage ovarian cancer can receive surgery, chemotherapy, and potentially still give birth.


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: The Expanding Role of PARP Inhibitors in the Treatment of Ovarian Cancers – Current Strategies and Future DirectionJan 30, 20181.5
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x